Search research articles
Contact Us
Filters
Showing results (601-610 of 659) with videos related to
Page
of 66
Sort By:
Blood Advances
|
March 8, 2023
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity
Alexandre Bazinet, Tapan Kadia, Nicholas J Short, et al.
Blood
|
March 29, 2024
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Yaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2024
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory <i>FLT3</i>-Mutated AML
Nicholas J Short, Naval Daver, Courtney D Dinardo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Yaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
NEJM Evidence
|
February 6, 2024
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS
Koji Sasaki, Elias Jabbour, Guillermo Montalban-Bravo, et al.
Cancers
|
April 13, 2023
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience
Adriana Trabal, Amber Gibson, Jiasen He, et al.
American Journal of Hematology
|
March 1, 2020
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Caleb A Class, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid Leukemia
Gandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
American Journal of Hematology
|
October 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study
Oren Pasvolsky, Shai Shimony, Rima M Saliba, et al.
The Lancet. Haematology
|
November 19, 2022
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
Elias Jabbour, Nicholas J Short, Nitin Jain, et al.
Page
of 66
Search research articles
Search
Showing results (601-610 of 659) with videos related to
Sort By:
Page
of 66
Blood Advances
|
March 8, 2023
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity
Alexandre Bazinet, Tapan Kadia, Nicholas J Short, et al.
Blood
|
March 29, 2024
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Yaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2024
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory <i>FLT3</i>-Mutated AML
Nicholas J Short, Naval Daver, Courtney D Dinardo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Yaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
NEJM Evidence
|
February 6, 2024
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS
Koji Sasaki, Elias Jabbour, Guillermo Montalban-Bravo, et al.
Cancers
|
April 13, 2023
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience
Adriana Trabal, Amber Gibson, Jiasen He, et al.
American Journal of Hematology
|
March 1, 2020
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Caleb A Class, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid Leukemia
Gandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
American Journal of Hematology
|
October 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study
Oren Pasvolsky, Shai Shimony, Rima M Saliba, et al.
The Lancet. Haematology
|
November 19, 2022
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
Elias Jabbour, Nicholas J Short, Nitin Jain, et al.
Page
of 66